Boutique value Target life sciences focus: Chestnut Partners specializes in financial advisory for life sciences, presenting a clear opportunity to offer growth equity, strategic partnerships, and M&A support aligned with biotech and pharma initiatives.

Unconflicted advice Distinctive selling point: As an objective, nonconflicted advisor, they can position collaboration with larger fund managers, SPVs, or corporate VC groups seeking trusted dealmakers to manage complex transactions without conflicts of interest.

Growth readiness Revenue scale and services indicate readiness for fundraising and private capital formation assistance; approach funds and investors in mid-market life sciences to support rounds, strategic partnerships, or tender defense financing.

Tech enablement Existing tech stack shows foundational digital capabilities; propose services that leverage data, due diligence, and deal execution tooling to streamline transactions and enhance client deliverables.

Network expansion Small firm profile with 11-50 employees suggests value in expanding strategic partnerships with larger PE firms and venture groups in the life sciences and healthcare sectors to scale deal sourcing and execution.